Related Experiment Video
Updated: Jan 8, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Institutional Variation in Fentanyl Use for Children on Extracorporeal Membrane Oxygenation
Rabab M Barq1,2, Shadassa Ourshalimian1, Olivia A Keane1,2
1Division of Pediatric Surgery, Children's Hospital Los Angeles, Los Angeles, California.
Insights
Fentanyl is commonly used for critically ill children on extracorporeal membrane oxygenation (ECMO), despite risks. Neonates and children with cardiovascular disease show higher fentanyl use, highlighting the need for better pain management guidelines.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Neonatology
Background:
- Fentanyl, an opioid analgesic, is frequently used for pain management in critically ill children.
- Its use during extracorporeal membrane oxygenation (ECMO) is cautioned against due to lipophilic properties increasing withdrawal risks.
- Understanding institutional variation in fentanyl use for pediatric ECMO patients is crucial.
Purpose of the Study:
- To evaluate institutional variations in fentanyl administration for children undergoing ECMO.
- To identify factors associated with fentanyl prescribing patterns in this vulnerable population.
Main Methods:
- Retrospective study of children (<18 years) on ECMO from 2016-2023.
- Data sourced from the Pediatric Health Information System.
- Multivariable hierarchical logistic regression analyzed factors linked to fentanyl use.
Main Results:
- 91.9% of 7731 children received fentanyl during ECMO, with significant institutional variability (13.4%-100%).
- Hospital differences accounted for 20.3% of variation in fentanyl use.
- Neonates (OR 2.35) and children with cardiovascular disease (OR 1.63) had higher odds of fentanyl use; premature infants had lower odds (OR 0.50).
Conclusions:
- Fentanyl remains prevalent in pediatric ECMO despite recognized risks.
- Significant institutional variation in fentanyl use exists, with neonates being most exposed.
- Enhanced guidelines for sedation and pain management in pediatric ECMO are urgently needed.
Objective:
Fentanyl is an opioid analgesic commonly used for pain management in children who are critically ill. However, fentanyl use is discouraged during extracorporeal membrane oxygenation (ECMO) because of its lipophilic and protein-binding properties. These properties have been shown to increase the risk of opioid withdrawal and other poor health outcomes. Our objectives were to evaluate institutional variation and the factors associated with fentanyl use for children on ECMO.
Patients And Methods:
This retrospective study included children aged less than 18 years who received ECMO between 2016 to 2023 at children's hospitals in the Pediatric Health Information System. Multivariable hierarchical logistic regression evaluated factors associated with fentanyl prescribing during ECMO.
Results:
Overall, 7731 children (54.5% male, 53.8% white, 48.6% neonatal) were included, with 91.9% receiving fentanyl during ECMO. Significant institutional variability was observed, with percent days of fentanyl use during ECMO ranging from 13.4% to 100%. Overall, 20.3% of the total variation in fentanyl use on ECMO was attributable to differences among hospitals. On multivariable regression, compared with adolescents, neonates (odds ratio [OR], 2.35; 95% CI, 1.61-3.43) had the highest likelihood of receiving fentanyl. Additionally, children with cardiovascular disease (OR, 1.63; 95% CI, 1.35-1.95) had an increased likelihood of receiving fentanyl, and children with a history of prematurity (OR, 0.50; 95% CI, 0.38-0.66) had a decreased likelihood.
Conclusion:
Despite its known risks, fentanyl remains widely used for children on ECMO. Additionally, significant institutional variation exists, with neonates having the highest risk of fentanyl exposure. Our findings underscore the need for enhanced guidelines for sedation and pain management for children receiving ECMO.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Delivery: Enteral Route
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

